• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Audio Journal of Oncology in Advance – October 1st, 2006

  • — 1 Oct, 2006
AudioMedica News
AudioMedica News
Audio Journal of Oncology in Advance - October 1st, 2006
Audio Journal of Oncology in Advance - October 1st, 2006
00:00 /
RSS Feed
Share
Link
Embed
George Canellos
George Canellos
Sandra Strauss
Sandra Strauss
Nancy Baxter
Nancy Baxter

KIT Mutations in Acute Myeloid Leukemia Confer Higher Relapse Risk
Liver Metastasis Resection Not Curative for Colorectal Cancer
Patients With Node Negative Breast Cancer: Low Risk After Mastectomy

REFERENCES: J Clin Oncol 34:3904, 3927, 3939
GEORGE CANELLOS, Dana-Farber Cancer Institute, Boston
In adult acute myeloid leukemia the detection of KIT mutations was associated with higher relapse risk, according to a study from Columbus, Ohio, reviewed by George Canellos. Dr Canellos also discussed findings from Paris that complete dissection of liver metastasis is not curative for colorectal cancer, and results from Boston that patients with large breast cancers removed by mastectomy may expect low locoregional recurrence rates if they are lymph-node negative, and therefore do not need postmastectomy radiotherapy.

Combination Immunotherapy: Promising For Patients With Refractory or Recurrent Non-Hodgkin’s Lymphoma

REFERENCE: J Clin Oncol 24:3880
SANDRA STRAUSS, Royal Free Hospital, London
COMMENT: George Canellos

A new combination of immunotherapy agents – the anti-CD22 antibody epratuzumab and the anti CD20 rituximab – has shown promise for the treatment of patients whose non-Hodgkin’s lymphoma is recurrent or has become refractory to standard therapy. Sandra Strauss of London’s Royal Free Hospital told Peter Goodwin about the findings from her study published in the Journal of Clinical Oncology.

Stage IIIB, IIIC Colon Cancer: Negative Lymph Nodes, Longer Survival

REFERENCE: J Clin Oncol 24:3570
NANCY BAXTER, St Michael’s Hospital, Toronto
COMMENT: George Canellos

In Stage III colon cancer having fewer negative lymph nodes leads to shorter survival, according to the findings of a study from St Michael’s Hospital in Toronto. Having more negative nodes is associated with longer survival. Nancy Baxter discussed the investigation with Derek Thorne.


[audio:https://www.audiomedica.com/podcasting/asco/061001_asco_podcast.mp3]

You may also like...

  • Daniel Hayes MD, Clinical Director of the Breast Oncology Program at the University of Michigan Cancer Center Ann Arbor Genetic Tests for Breast Cancer Late Recurrence Risk—Not Yet Ready for Prime Time 24 Mar, 2015
  • John Mendelsohn The WIN consortium meets in Paris – a boost for cancer science 17 Jul, 2013
  • Oncology Times Broadcast News with the Audio Journal of Oncology – Bilateral Prophylactic Mastectomy For DCIS Oncology Times Broadcast News with the Audio Journal of Oncology – Bilateral Prophylactic Mastectomy For DCIS 6 Apr, 2009
  • Powel Brown MD, Chairman of the Department of Clinical Cancer Prevention at the University of Texas MD Anderson Cancer Center in Houston New Strategies for Preventing ER-Negative Breast Cancer 23 Mar, 2015
  • Previous story Reporting from the 2006 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, San Francisco
  • Next story Audio Journal of Medicine: Reporting from the 2006 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, San Francisco
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Genomic-led AML Clinical Decision Making Within Seven Days
    • Ibrutinib: New Frontline Standard for Chronic Lymphocytic…
    • New Front Line Standard for Older Patients with Chronic…
    • Microbiome Diversity Key To Survival After Allogeneic…
    • CT Screening Cuts Lung Cancer Deaths 24 Per Cent—Second…
  • Home
  • Oncology
  • AJO
  • Audio Journal of Oncology in Advance – October 1st, 2006

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.